foxo4 dri peptide senolytic 2023 FOXO4-DRI For Sale (10mg) FOXO4-DRI regulates endothelial cell senescence
FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect
Pay in 4 interest-free payments of $5.12 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



